For example, individuals with hepatocellular carcinoma (HCC) had significantly reduced levels of the critical cuproptosis regulator FDX1, making HCC cells resistant to cuproptosis (Zhang Z. et al., 2022). This evidence concerns the gene FDX1 and hepatocellular carcinoma.